Use of osteogenic protein-1 in patients at high risk for spinal pseudarthrosis: A prospective cohort study assessing safety, health-related quality of life, and radiographic fusion

Journal of Neurosurgery: Spine

Volumn 7, Issue 5, 2007, Pages 486-495

  Furlan, Julio C ^a,b   Perrin, Richard G ^a,b   Govender, Preneshlin V ^a,b   Petrenko, Yuriy ^a,b   Massicotte, Eric M ^a,b   Rampersaud, Yoga R ^b   Lewis, Stephen ^b   Fehlings, Michael G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

36 item short form health survey; Bone morphogenetic protein 7; Osteogenic protein 1; Oswestry disability index; Radiographic fusion; Spinal pseudarthrosis

Indexed keywords

COLLAGEN; OSTEOGENIC PROTEIN 1;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CANADA; CLINICAL ARTICLE; COHORT ANALYSIS; DISABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MALE; MEASUREMENT ERROR; OSSIFICATION; OSWESTRY DISABILITY INDEX; PROSPECTIVE STUDY; PSEUDARTHROSIS; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SPINAL PSEUDOARTHROSIS; SPINE DISEASE; SPINE FUSION; SPINE RADIOGRAPHY; SPONDYLOSIS;

EID: 35948931791     PISSN: 15475654     EISSN: None     Source Type: Journal    
DOI: 10.3171/SPI-07/09/486     Document Type: Article

References (40)

1. Beaton DE, Schemitsch E: Measures of health-related quality of life and physical function. Clin Orthop Relat Res 413:90-105, 2003
2. Carlisle E, Fischgrund JS: Bone morphogenetic proteins for spinal fusion. Spine J 5 (6 Suppl):240S-249S, 2005
3. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al: Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 87:9843-9847, 1990
4. Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 22:233-241, 2004
5. Chou J, Harvey BK, Chang CF, Shen H, Morales M, Wang Y: Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci 240:21-29, 2006
6. Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger DC, Kuettner KE: Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 1588:126-134, 2002
7. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud TS III: The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76:827-838, 1994
8. Cook SD, Dalton JE, Tan EH, Whitecloud TS III, Rueger DC: In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19:1655-1663, 1994
9. Cook SD, Wolfe MW, Salkeld SL, Rueger DC: Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77:734-750, 1995
10. Cunningham BW, Shimamoto N, Sefter JC, Dmitriev AE, Orbegoso CM, McCarthy EF, et al: Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction. Spine J 2:11-24, 2002
11. Ducy P, Karsenty G: The family of bone morphogenetic proteins. Kidney Int 57:2207-2214, 2000
12. Fairbank JC, Couper J, Davies JB, O'Brien JP: The Oswestry low back pain disability questionnaire. Physiotherapy 66:271-273, 1980
13. Geesink RG, Hoefnagels NH, Bulstra SK: Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81:710-718, 1999
14. Grauer JN, Patel TC, Erulkar JS, Troiano NW, Panjabi MM, Friedlaender GE: 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 26:127-133, 2001
15. Grauer JN, Vaccaro AR, Kato M, Kwon BK, Beiner JM, Patel TC, et al: Development of a New Zealand white rabbit model of spinal pseudarthrosis repair and evaluation of the potential role of OP-1 to overcome pseudarthrosis. Spine 29:1405-1412, 2004
16. Hägg O, Fritzell P, Nordwall A: The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 12:12-20, 2003
17. Hak DJ, Makino T, Niikura T, Hazelwood SJ, Curtiss S, Reddi AH: Recombinant human BMP-7 effectively prevents non-union in both young and old rats. J Orthop Res 24:11-20, 2006
18. Johnsson R, Stromqvist B, Aspenberg P: Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. Spine 27:2654-2661, 2002
19. Kanayama M, Hashimoto T, Shigenobu K, Yamane S, Bauer TW, Togawa D: A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine 31:1067-1074, 2006
20. Li T, Surendran K, Zawaideh MA, Mathew S, Hruska KA: Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr Opin Nephrol Hypertens 13:417-422, 2004
21. Magin MN, Delling G: Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep. Spine 26:469-478, 2001
22. Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, et al: Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J Cell Physiol 196:258-264, 2003
23. Moazzaz P, Gupta MC, Gilotra MM, Gilotra MN, Maitra S, Theerajunyaporn T, et al: Estrogen-dependent actions of bone morphogenetic protein-7 on spine fusion in rats. Spine 30:1706-1711, 2005
24. Mofidi A, Sedhom M, O'Shea K, Moore D, Fogarty E, Dowling F: Usefulness of functional outcome questionnaires in primary screening of spinal disease. J Spinal Disord Tech 16:66-70, 2003
25. Patel TC, Erulkar JS, Grauer JN, Troiano NW, Panjabi MM, Friedlaender GE: Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. Spine 26:1656-1661, 2001
26. Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB: Assessing health-related quality of life in patients with sciatica. Spine 20:1899-1909, 1995
27. Rampersaud YR, Moro ER, Neary MA, White K, Lewis SJ, Massicotte EM, et al: Intraoperative adverse events and related postoperative complications in spine surgery: implications for enhancing patient safety founded on evidence-based protocols. Spine 31:1503-1510, 2006
28. Reddi AH: Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247-252, 1998
29. Riddle DL, Stratford PW: Use of generic versus region-specific functional status measures on patients with cervical spine disorders. Phys Ther 78:951-963, 1998
30. Ripamonti U: Bone induction by recombinant human osteogenic protein-1 (hOP-1, BMP-7) in the primate Papio ursinus with expression of mRNA of gene products of the TGF-beta superfamily. J Cell Mol Med 9:911-928, 2005
31. Slover J, Abdu WA, Hanscom B, Weinstein JN: The impact of comorbidities on the change in short-form 36 and oswestry scores following lumbar spine surgery. Spine 31:1974-1980, 2006
32. Urist MR: Bone: formation by autoinduction. Science 150:893-899, 1965
33. Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, Herkowitz HN, et al: Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 30:2709-2716, 2005
34. Vaccaro AR, Anderson DG, Toth CA: Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion. Spine 27 (1 Suppl):S59-S65, 2002
35. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H, et al: A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 12:495-500, 2003
36. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz HN, et al: A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 29:1885-1892, 2004
37. Walsh TL, Hanscom B, Lurie JD, Weinstein JN: Is a condition-specific instrument for patients with low back pain/leg symptoms really necessary? The responsiveness of the Oswestry Disability Index, MODEMS, and the SF-36. Spine 28:607-615, 2003
38. Ware JE Jr: Conceptualizing and measuring generic health outcomes. Cancer 67 (3 Suppl):774-779, 1991
39. Ware JE Jr, Kosinski M: SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1, ed 2. Lincoln, RI: Quality Metric Incorporated, 2001
40. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P: Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65:5769-5777, 2005